In an effort to promote the coverage of live violin performance, Violinist.com each week presents links to reviews of notable ...
Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75%, reported ...
FORT WAYNE, Ind., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the "Company”) today announced that it ...
Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...
FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night ...
The 21st dispensary enhances patient access to premium medical cannabis with interactive product displays and a commitment to community engagementNEW YORK and TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) - ...